Abstract
Background
Laparoscopic single anastomosis (mini-)gastric bypass (LSAGB) has been validated as a safe and effective treatment for morbid obesity. However, data of the long-term outcome remain lacking.
Methods
Between October 2001 and December 2015, 1731 morbidly obese patients who received LSAGB as primary bariatric procedure at the Min-Sheng General Hospital were recruited. Surgical outcome, weight loss, resolution of comorbidities, and late complications were followed, then compared with groups of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG). All data derived from a prospective bariatric database and a retrospective analysis were conducted.
Results
The average patient age was 33.8 ± 10.4 years with a mean body mass index (BMI) of 40.4 ± 7.7 kg/m2. Of them, 70.0% were female while 30.0% were male. Mean operating time, intraoperative blood, and hospital stay of LSAGB were 124.6 ± 38.8 min, 39.5 ± 38.7 ml, and 5.0 ± 4.1 days, respectively. The 30-day post-operative major complication occurred in 30 (1.7%) of LSAGB patients, 16 (2.0%) of LRYGB, and 15 (1.4%) of LSG patients. The follow-up rates at 1, 5, and 10 years were 89.3, 52.1, and 43.6%, respectively. At postoperative 1, 5, and 10 years, the mean percentage of weight loss (%WL) of LSAGB patients were 32.7, 32.2, and 29.1%, and mean BMI became 27, 26.9, and 27 kg/m2, respectively. The LSAGB had a higher weight loss than LRYGB and LSG at 2–6 years after surgery. LSG had a lower remission rate in dyslipidemia comparing to LSAGB and LRYGB. The overall revision rate of LSAGB is 4.0% (70/1731) which was lower than the 5.1% in LRYGB and 5.2% in the LSG.
Conclusion
LSAGB is an effective procedure for treating morbid obesity and metabolic disorders, which results in sustained weight loss and a high resolution of comorbidities.
Similar content being viewed by others
References
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson L (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23(4):427–436
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832
Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11(3):276–280. https://doi.org/10.1381/096089201321336584
Noun R, Skaff J, Riachi E, Daher R, Antoun N, Nasr M (2012) One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg 22:697–703
Lee WJ, Yu PJ, Wang W, Huang MT (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg 242:20–28
Tacchino RM, Greco F, Matera D, Diflumeri G (2010) Single-incision laparoscopic gastric bypass for morbid obesity. Obes Surg 20:1154–1160
Bruzzi M, Rau C, Voron T, Guenzi M, Berqer A, Chevallier JM (2015) Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis 11:321–326
Fisher BL, Buchwald H, Clark W et al (2001) Mini-gastric bypass controversy. Obes Surg 11(6):773–777
Lee WJ, Lin YH (2014) Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg 24:1749–1756
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Ser KH, Lee WJ, Lee YC, Chen JC, Su YH, Chen SC (2010) Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surg Endosc 24(9):2253–2259
Pok EH, Lee WJ, Ser KH, Chen JC, Chen SC, Tsou JJ, Chin KF (2016) Laparoscopic sleeve gastrectomy in Asia: long term outcome and revisional surgery. Asian J Surg 39:21–28
Jammu G, Sharma R (2016) A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg 26:926–932
Genser L, Carandina S, Tabbara M, Torcivia A, Soprani A, Siksik JM, Cady J (2016) Presentation and surgical management of leaks after mini-gastric bypass for morbid obesity. Surg Obes Relat Dis 12:305–312
Lee WJ, Ser KH, Lee YC, Tsou JJ, Chen SC, Chen JC (2012) Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg 27:623–631
Paroz A, Calmes JM, Giusti V, Suter M (2006) Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a continuous challenge in bariatric surgery. Obes Surg 16:1482–1487
Chowbey P, Baijal M, Kantharia N, Khullar R, Sharma A, Soni V (2016) Mesenteric defect closure decreases the incidence of internal hernias following laparoscopic Roux-en-Y gastric bypass: a retrospective cohort study. Obes Surg 26:2029–2034
Koner J, Inabnet W, Febres G, Conwell I, McMahon D, Salas R, Taveras C, Schrope B, Bessler M (2009) Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes 33:786–793
Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD (2011) Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 7:683–690
Venciauskas L, Johannes S, Emst A et al (2014) Short vs. long biliopancreatic limb gastric bypass for treatment of T2DM, randomized controlled study. Obes Surg 24:1149–1150
Caruana JA, Monte SV, Jacobs DM, Voytovich C, Ghanim H, Dandona P (2015) Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at < 70% bypass. Surg Obes Relat Dis 11:1248–1256
Miyachi T, Nagao M, Shikashi S, Kitahara Y, Tanaka N, Watanabe K, Tsuchiya T, Motoi F, Naitoh T, Unno M (2016) Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes. Surgery 159(5):1360–1371
Flum DR, Dellinger P (2004) Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199:543–551
Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chung LM (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146(2):143–148
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Narwaf Alkhalifah, Dr. Wei-Jei Lee, Dr. Tan Chun Hai, Dr. Kong-Han Ser, Dr. Jung-Chieh Chen, Dr. Chun-Chi Wu have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Alkhalifah, N., Lee, WJ., Hai, T.C. et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc 32, 3024–3031 (2018). https://doi.org/10.1007/s00464-017-6011-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-017-6011-1